Literature DB >> 16299277

Demonstration of OspC type diversity in invasive human lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response.

Christopher G Earnhart1, Eric L Buckles, John Stephen Dumler, Richard T Marconi.   

Abstract

Outer surface protein C (OspC) of the Lyme disease spirochetes is an important virulence factor that has potential utility for vaccine development. Of the 21 OspC types that have been identified, it has been postulated that types A, B, I, and K are specifically associated with invasive infections. Through an analysis of isolates collected from patients in Maryland we found that OspC types C, D, and N are also associated with invasive infections. This observation suggests that there is greater diversity in the group of OspC types associated with invasive infection than has been previously suggested. Detailed knowledge of the antigenic structure of OspC is essential for vaccine development. To determine if the antibody response to OspC is type specific, recombinant proteins of several different OspC types were immunoblotted and screened with sera from mice infected with isolates having known OspC types. These analyses revealed a high degree of specificity in the antibody response and suggested that the immunodominant epitopes of OspC reside in the variable domains of the protein. To localize these epitopes, OspC fragments were generated and screened with serum collected from infected mice. These analyses led to identification of previously uncharacterized epitopes that define the type specificity of the OspC antibody response. These analyses provide important insight into the antigenic structure of OspC and also provide a basis for understanding the variable nature of the antibody response to this important virulence factor of the Lyme disease spirochetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16299277      PMCID: PMC1307023          DOI: 10.1128/IAI.73.12.7869-7877.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi.

Authors:  C Eicken; V Sharma; T Klabunde; R T Owens; D S Pikas; M Höök; J C Sacchettini
Journal:  J Biol Chem       Date:  2001-01-03       Impact factor: 5.157

2.  Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection.

Authors:  S Y Sung; J V McDowell; J A Carlyon; R T Marconi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Borrelia burgdorferi ospC heterogeneity among human and murine isolates from a defined region of northern Maryland and southern Pennsylvania: lack of correlation with invasive and noninvasive genotypes.

Authors:  Muneera Y Alghaferi; Jennifer M Anderson; Jinho Park; Paul G Auwaerter; John N Aucott; Douglas E Norris; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

4.  Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  D Kumaran; S Eswaramoorthy; B J Luft; S Koide; J J Dunn; C L Lawson; S Swaminathan
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

5.  Environmental regulation and differential production of members of the Bdr protein family of Borrelia burgdorferi.

Authors:  David M Roberts; Melissa Caimano; John McDowell; Michael Theisen; Arne Holm; Edward Orff; David Nelson; Stephen Wikel; Justin Radolf; Richard T Marconi
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

6.  Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway.

Authors:  A Hübner; X Yang; D M Nolen; T G Popova; F C Cabello; M V Norgard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

7.  Analysis of the OspE determinants involved in binding of factor H and OspE-targeting antibodies elicited during Borrelia burgdorferi infection in mice.

Authors:  Michael S Metts; John V McDowell; Michael Theisen; Paul Robert Hansen; Richard Thomas Marconi
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

8.  Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes.

Authors:  John V McDowell; Shian-Ying Sung; Linden T Hu; Richard T Marconi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

9.  Transcriptional regulation of the ospAB and ospC promoters from Borrelia burgdorferi.

Authors:  Janet Alverson; Sharyl F Bundle; Charles D Sohaskey; Meghan C Lybecker; D Scott Samuels
Journal:  Mol Microbiol       Date:  2003-06       Impact factor: 3.501

10.  Inability of outer-surface protein C (OspC)-primed mice to elicit a protective anamnestic immune response to a tick-transmitted challenge of Borrelia burgdorferi.

Authors:  Robert D Gilmore; Rendi M Bacon; Amber M Carpio; Joseph Piesman; Marc C Dolan; M Lamine Mbow
Journal:  J Med Microbiol       Date:  2003-07       Impact factor: 2.472

View more
  63 in total

Review 1.  Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.

Authors:  Jerilyn R Izac; Richard T Marconi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2019-04-06       Impact factor: 2.093

2.  Cross-Immunity and Community Structure of a Multiple-Strain Pathogen in the Tick Vector.

Authors:  Jonas Durand; Maxime Jacquet; Lye Paillard; Olivier Rais; Lise Gern; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Vaccine       Date:  2007-01-17       Impact factor: 3.641

4.  Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Authors:  Eric L Buckles; Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2006-10

5.  Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals.

Authors:  John V McDowell; Kelley M Hovis; Hongming Zhang; Emily Tran; Justin Lankford; R T Marconi
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

6.  OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

7.  The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans.

Authors:  Daniel E Dykhuizen; Dustin Brisson; Sabina Sandigursky; Gary P Wormser; John Nowakowski; Robert B Nadelman; Ira Schwartz
Journal:  Am J Trop Med Hyg       Date:  2008-05       Impact factor: 2.345

Review 8.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

9.  BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.

Authors:  Adam S Coleman; Utpal Pal
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  Maternal Antibodies Provide Bank Voles with Strain-Specific Protection against Infection by the Lyme Disease Pathogen.

Authors:  Andrea Gomez-Chamorro; Vanina Heinrich; Anouk Sarr; Owen Roethlisberger; Dolores Genné; Cindy Bregnard; Maxime Jacquet; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2019-11-14       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.